- HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells
[作者:Ho, IAW; Chan, KYW; Miao, L; Shim, WSN; Guo, CM; Cheang, P; Hui, KM; Lam, PYP,期刊:Cancer gene therapy, 页码:553-562 , 文章类型: Article,,卷期:2008年15-9]
- Human bone marrow-derived mesenchymal stem cells (BM-hMSCs) are nonhematopoietic stem cells that have the potential to differentiate into adipocytes, osteocytes and chondrocytes. Because of its propensity to migrate to t...
- Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma
[作者:Lorico, A; Mercapide, J; Soloduschko, V; Alexeyev, M; Fodstad, O; Rappa, G,期刊:Cancer gene therapy, 页码:605-615 , 文章类型: Article,,卷期:2008年15-9]
- Despite recent technical improvements in surgical excision techniques and adjuvant radio- and chemotherapy, the clinical outcome of patients with grade IV astrocytoma ( glioblastoma) remains very poor, with a median surv...
- JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase
[作者:Hu, W; Hofstetter, W; Guo, W; Li, H; Pataer, A; Peng, HH; Guo, ZS; Bartlett, DL; Lin, A; Swisher, SG; Fang, B,期刊:Cancer gene therapy, 页码:616-624 , 文章类型: Article,,卷期:2008年15-9]
- Vaccinia virus has recently been used as an expression vector for gene delivery and an oncolytic agent for cancer therapy. Although it has been established that interferon-induced double-stranded RNA (dsRNA)-activated pr...
|